Treatment of thyrotoxic hypercalcemia with propranolol.

Suppr

超能文献

作者信息

Rude R K, Oldham S B, Singer F R, Nicoloff J T

出版信息

N Engl J Med. 1976 Feb 19;294(8):431-3. doi: 10.1056/NEJM197602192940807.

DOI:10.1056/NEJM197602192940807

PMID:1246310

Abstract

摘要

相似文献

Treatment of thyrotoxic hypercalcemia with propranolol.

N Engl J Med. 1976 Feb 19;294(8):431-3. doi: 10.1056/NEJM197602192940807.

Letter: Thyrotoxic hypercalcemia treated with propranolol.

N Engl J Med. 1976 May 13;294(20):1123-4. doi: 10.1056/nejm197605132942020.

Oral propranolol in hypercalcemia associated with apathetic thyrotoxicosis.

Am J Med Sci. 1978 Mar-Apr;275(2):199-202. doi: 10.1097/00000441-197803000-00011.

[Hypercalcemia as first manifestation of thyrotoxicosis (author's transl)].

Med Clin (Barc). 1980 Feb 10;74(3):107-8.

Control of hypercalcaemia in thyrotoxicosis.

Postgrad Med J. 1979 Dec;55(654):891-3. doi: 10.1136/pgmj.55.650.891.

Propranolol and the hypercalcaemia of thyrotoxicosis.

Acta Endocrinol (Copenh). 1981 Dec;98(4):528-32. doi: 10.1530/acta.0.0980528.

Thyrotoxic hypercalcemia treated with corticosteroids.

Acta Med Scand. 1980;207(6):499-501. doi: 10.1111/j.0954-6820.1980.tb09761.x.

Propranolol and serum calcium in thyrotoxicosis.

Br Med J. 1970 Aug 29;3(5721):525-6. doi: 10.1136/bmj.3.5721.525-d.

Symptomatic thyrotoxic hypercalcemia.

Mich Med. 1974 Jan;73(2):19-24.

[Hypercalcemia and hyperphosphatemia in thyrotoxoicosis and the therapeutic effect of propranolol].

Zhonghua Nei Ke Za Zhi. 1989 Nov;28(11):646-8, 699.

引用本文的文献

Global Disruption of α2A Adrenoceptor Barely Affects Bone Tissue but Minimizes the Detrimental Effects of Thyrotoxicosis on Cortical Bone.

Front Endocrinol (Lausanne). 2018 Aug 28;9:486. doi: 10.3389/fendo.2018.00486. eCollection 2018.

Lack of α2C-Adrenoceptor Results in Contrasting Phenotypes of Long Bones and Vertebra and Prevents the Thyrotoxicosis-Induced Osteopenia.

PLoS One. 2016 Jan 27;11(1):e0146795. doi: 10.1371/journal.pone.0146795. eCollection 2016.

Causes of anorexia in untreated hyperthyroidism: a prospective study.

Postgrad Med J. 2000 May;76(895):292-4. doi: 10.1136/pmj.76.895.292.

Hypercalcaemia due to thyrotoxicosis.

Ir J Med Sci. 1983 Nov;152(11):422-3. doi: 10.1007/BF02958811.

Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Drugs. 1984 May;27(5):425-46. doi: 10.2165/00003495-198427050-00003.

Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Clin Pharmacokinet. 1983 Jan-Feb;8(1):1-16. doi: 10.2165/00003088-198308010-00001.

Effect of thyrotoxicosis and its treatment on mineral and bone metabolism.

J Endocrinol Invest. 1986 Dec;9(6):491-6. doi: 10.1007/BF03346972.

Calcium metabolism in thyroid disease.

J Endocrinol Invest. 1988 Jan;11(1):61-9. doi: 10.1007/BF03350101.

Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate.

Postgrad Med J. 1988 Mar;64(749):224-7. doi: 10.1136/pgmj.64.749.224.

Does atenolol have an effect on calcium metabolism?

Br Med J (Clin Res Ed). 1987 Jul 4;295(6589):53. doi: 10.1136/bmj.295.6589.53.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Treatment of thyrotoxic hypercalcemia with propranolol.

N Engl J Med. 1976 Feb 19;294(8):431-3. doi: 10.1056/NEJM197602192940807.

Letter: Thyrotoxic hypercalcemia treated with propranolol.

N Engl J Med. 1976 May 13;294(20):1123-4. doi: 10.1056/nejm197605132942020.

Oral propranolol in hypercalcemia associated with apathetic thyrotoxicosis.

Am J Med Sci. 1978 Mar-Apr;275(2):199-202. doi: 10.1097/00000441-197803000-00011.

[Hypercalcemia as first manifestation of thyrotoxicosis (author's transl)].

Med Clin (Barc). 1980 Feb 10;74(3):107-8.

Control of hypercalcaemia in thyrotoxicosis.

Postgrad Med J. 1979 Dec;55(654):891-3. doi: 10.1136/pgmj.55.650.891.

Propranolol and the hypercalcaemia of thyrotoxicosis.

Acta Endocrinol (Copenh). 1981 Dec;98(4):528-32. doi: 10.1530/acta.0.0980528.

Thyrotoxic hypercalcemia treated with corticosteroids.

Acta Med Scand. 1980;207(6):499-501. doi: 10.1111/j.0954-6820.1980.tb09761.x.

Propranolol and serum calcium in thyrotoxicosis.

Br Med J. 1970 Aug 29;3(5721):525-6. doi: 10.1136/bmj.3.5721.525-d.

Symptomatic thyrotoxic hypercalcemia.

Mich Med. 1974 Jan;73(2):19-24.

[Hypercalcemia and hyperphosphatemia in thyrotoxoicosis and the therapeutic effect of propranolol].

Zhonghua Nei Ke Za Zhi. 1989 Nov;28(11):646-8, 699.

引用本文的文献

Global Disruption of α2A Adrenoceptor Barely Affects Bone Tissue but Minimizes the Detrimental Effects of Thyrotoxicosis on Cortical Bone.

Front Endocrinol (Lausanne). 2018 Aug 28;9:486. doi: 10.3389/fendo.2018.00486. eCollection 2018.

Lack of α2C-Adrenoceptor Results in Contrasting Phenotypes of Long Bones and Vertebra and Prevents the Thyrotoxicosis-Induced Osteopenia.

PLoS One. 2016 Jan 27;11(1):e0146795. doi: 10.1371/journal.pone.0146795. eCollection 2016.

Causes of anorexia in untreated hyperthyroidism: a prospective study.

Postgrad Med J. 2000 May;76(895):292-4. doi: 10.1136/pmj.76.895.292.

Hypercalcaemia due to thyrotoxicosis.

Ir J Med Sci. 1983 Nov;152(11):422-3. doi: 10.1007/BF02958811.

Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Drugs. 1984 May;27(5):425-46. doi: 10.2165/00003495-198427050-00003.

Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Clin Pharmacokinet. 1983 Jan-Feb;8(1):1-16. doi: 10.2165/00003088-198308010-00001.

Effect of thyrotoxicosis and its treatment on mineral and bone metabolism.

J Endocrinol Invest. 1986 Dec;9(6):491-6. doi: 10.1007/BF03346972.

Calcium metabolism in thyroid disease.

J Endocrinol Invest. 1988 Jan;11(1):61-9. doi: 10.1007/BF03350101.

Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate.

Postgrad Med J. 1988 Mar;64(749):224-7. doi: 10.1136/pgmj.64.749.224.

Does atenolol have an effect on calcium metabolism?

Br Med J (Clin Res Ed). 1987 Jul 4;295(6589):53. doi: 10.1136/bmj.295.6589.53.